newsfilter
← Latest News
Business Wire·

enGene to Participate in Upcoming Investor Conferences

enGene Therapeutics Inc. (NASDAQ:ENGN, "enGene" or the "Company")), a clinical-stage, non-viral genetic medicines company today announced that management will participate in the following investor